MCF7 cultures were treated with either MBC-005 or doxorubicin. by Bryan S. Margulies (21492667)

Subjects:

Normal fetus at 32 weeks of gestation. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

Subjects:

Liver samples were stained with hematoxylin and eosin and imaged at 4x. by Bryan S. Margulies (21492667)

Subjects:

Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

Subjects:

Study Design. by Bryan S. Margulies (21492667)

Subjects:

Maternal and fetoplacental characteristics of the study population. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Liver weights were normalized by the mouse body weight to derive the %liver weight. by Bryan S. Margulies (21492667)

Subjects:

Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Histomorphometric analysis of the tumor volume fraction (V_f) in the liver and necrosis volume fraction. by Bryan S. Margulies (21492667)

Subjects:

(A) Release rate (i.e., elution) of N-allyl noroxymorphone hydrochloride evaluated using UPLC from two samples of MBC-005. The equations predict that at 24-hours there will be betw... by Bryan S. Margulies (21492667)

Subjects:

Survival in mice with liver metastases after MBC-005 TREATMENT. by Bryan S. Margulies (21492667)

Subjects:

Inhibitor versus the normalized dose response curves. by Bryan S. Margulies (21492667)

Subjects:

Viscosity assessed using a tuning-fork viscometer. by Bryan S. Margulies (21492667)

Subjects:

Distribution of regions in which total blood flow, wall shear stress and pressures are below a 5% (dark green), 10% (medium green), and 15% (light green) change in the whole fetal... by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Interpolated survival in mice with or without lung metastases. by Bryan S. Margulies (21492667)

Subjects:

Most important percentage changes in CoA scenarios. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Velocity tracings of the healthy controls in our cohort.) by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Physiological regions considering ventricular depth variations. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Comparison of the computational model’s healthy baseline simulated traces (black) with those obtained by ultrasound from control cases (grey), after manually tuning the model’s par... by Inmaculada Villanueva-Baxarias (21454246)

Subjects: